A novel AI tool, DrugProtAI, promises to transform drug development by accurately identifying proteins that can be targeted by medicines, addressing a major hurdle in clinical research.

Researchers use mass spectrometry to determine the intensity of Covid-19 infection. 

In India, one woman dies of cervical cancer every 8 minutes, and for every two women newly diagnosed with breast cancer, one succumbs to it. In 2018, all over the country, 7,84,821 people lost their lives to cancer. Numerous scientific research is underway to discover new and improved drugs for cancer. Chemotherapy, where anti-cancer drugs are administered to kill cancerous cells, is one of the traditional and most successful treatment methods. In a recent study, Dr Sumit Ghosh, from the Indian Institute of Technology, Kanpur, discusses cisplatin, the first-ever metal-based drug used in chemotherapy.

Antimicrobials, a class of drugs used in humans and animals to treat diseases caused by bacteria, fungi, and parasites serve as a proxy for good hygiene and make up for the poor husbandry practices in animal farms in low and middle-income countries around the world. However, this dereliction comes with a considerable cost wherein, the overuse of these drugs has led to these microbes developing resistance against the very same drugs used to kill them.  Antimicrobial resistance (AMR) in humans is linked to several animals, especially those that are raised for food. Despite this knowledge, it has received little attention in the world of animal science. A new study, published in the journal Science, has mapped the global trends of antimicrobial resistance in farm animals, with particular focus on developing countries, including India. 

The whole world is struggling with the problem of antibiotic resistance developed by disease causing organisms. The epidemic of Tuberculosis especially plagues countries like India. In their recent research scientists from the Central University, Punjab have identified a new target drug to beat the bacteria’s defense against antibiotics.